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Abstract In the global perspective of antibiotic resistance,
it is urgent to find potent topical antibiotics for the use in
human and animal infection. Healing of equine wounds,
particularly in the limbs, is difficult due to hydrostatic
factors and exposure to environmental contaminants, which
can lead to heavy bio-burden/biofilm formation and
sometimes to infection. Therefore, antibiotics are often
prescribed. Recent studies have shown that honeybee-
specific lactic acid bacteria (LAB), involved in honey
production, and inhibit human wound pathogens. The aim
of this pilot study was to investigate the effects on the
healing of hard-to-heal equine wounds after treatment with
these LAB symbionts viable in a heather honey formula-
tion. For this, we included ten horses with wound duration
of[1 year, investigated the wound microbiota, and treated
wounds with the novel honeybee LAB formulation. We
identified the microbiota using MALDI-TOF mass spec-
trometry and DNA sequencing. In addition, the antimi-
crobial properties of the honeybee LAB formulation were
tested against all wound isolates in vitro. Our results
indicate a diverse wound microbiota including fifty-three
bacterial species that showed 90 % colonization by at least
one species of Staphylococcus. Treatment with the for-
mulation promoted wound healing in all cases already after
the first application and the wounds were either completely
healed (n = 3) in less than 20 days or healing was in
progress. Furthermore, the honeybee LAB formulation
inhibited all pathogens when tested in vitro. Consequently,
this new treatment option presents as a powerful candidate
for the topical treatment of hard-to-heal wounds in horses.
Introduction
We are facing a global increase in bacterial resistance to
conventional antibiotics that makes researchers around the
world investigate alternative tools to reduce this need in
both human and animal infection [60]. There are many
reasons for this antibiotic resistance crisis both from the
bacterial resistance mechanism and societal perspective,
but a significant issue is due to the therapeutic and pro-
phylactic over-use of antibiotics in pharmaceutical, dairy,
and food industry and the huge volumes of waste that is
generated from these industries [22, 37]. It is estimated in
the US alone 23 9 106 kg of antibiotics are used annually
[31]. In the European Union, there is much restrictions on
the use of antibiotics in agriculture and food industry yet in
many cases, it varies vastly between countries [36]. In
Sweden, it is mandate that antimicrobial growth promoters
are completely restricted in food and animal production
without veterinary prescription and only to cure or prevent
disease [61]. However, due to the over-use in other areas of
veterinary care such as over-prescription because of
patient/owner demands or bacterial misdiagnosis [37],
antibiotic resistance in the veterinary community is still
occurring at an alarming rate in some cases [4, 48]. Chronic
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wound management is facing the same issues when it
comes to finding potent topical antiseptics/antimicrobials
that are sustainable, broad spectrum, cost effective, and
environmentally friendly [32]. Due to the expenses asso-
ciated with maintaining and keeping horses healthy and
pleased, many owners are desperate to find suitable treat-
ments for persistent wounds.
The physical nature of the horse and their natural outdoor
habitat puts them at risk for many traumatic injuries, com-
monly skin and soft tissue wounds located on the limbs.
Objects from their surrounding environment often cause
these wounds, such as fences or gates. Contaminants from
soil can often leads to colonization, infection and finally to
disrupted healing [58]. In some cases, wound infection can
lead to Pastern Dermatitis (mud fever) [16]. Wounds on the
limbs of horses havemany similarities withwound healing in
humans. The hydrostatic forces of the limbs cause risk of
micro- and even macro-edema similar to human leg ulcers,
which compromises wound healing with the progression
following the same phases in hard-to-heal human wounds
such as inflammation, granulation, epithelialization, and
contraction [17]. These phases are influenced by numerous
factors, which can cause delayed healing of which the bio-
burden is an important one [51]. Equine wounds tend to have
a diverse environment of bacteria, similar to that of human
chronic wounds, with many different species implicated in
causing the infection, and possibly biofilm formation [59].
The treatment of equine wounds is becoming progressively
difficult due to increase of antibiotic-resistant bacterial
strains (e.g., Methicillin-Resistant Staphylococcus aureus
(MRSA). This is explained by the mentioned over-use of
antibiotics as well as a lack of appropriate topical wounds
treatments [10, 50, 57].
For thousands of years, honey has been used as a folk
medicine in treating infections [19, 29, 33, 46], and now, it
is being investigated further in treating wound infections in
humans [26] and animals [13]. The antimicrobial activity
of honey is largely attributed to its hygroscopic nature,
high osmolality, low pH, hydrogen peroxide content
[26, 30], and in the case of Manuka honey (one of the most
widely used in medicine), the antimicrobial substance
Methylglyoxal (MGO) [1]. MGO is believed to originate in
the nectar of the flowers of the Manuka tree (Leptosper-
mum scoparium); however, this substance can also be
produced by microorganisms [1, 8] including some lactic
acid bacteria (LAB) species [20, 34]. Manuka honey was
investigated in the treatment of Equine Pastern Dermatitis
with some success [21], though other studies have shown
that there may be other honey types that possess equal or
similar healing properties in animal and human wounds,
such as Heather honey [13] suggesting other mechanisms
of action [30].
Previously Olofsson and Va´squez discovered a symbi-
otic group of LAB composed of nine Lactobacillus species,
two Bifidobacterium species and two Bifidobacterium
phylotypes currently undergoing description as novel spe-
cies, found in the honey crop of the western honeybee Apis
mellifera [39, 55]. Notably, although often referred to as
LAB, Bifidobacteria are not typical representatives of LAB
as their main product of fermentation is acetic acid, not
lactic acid. These LAB symbionts, of which the majority
were recently described as novel species [40], are involved
in the production of honey and are viable in all types of
freshly harvested honey in extraordinary concentrations
(108 LAB per gram of fresh honey) [54, 56]. Further
investigations have been performed to reveal if these bac-
terial symbionts are the key reasons to honey’s antimi-
crobial and therapeutic properties independently of its
geographic or nectar origin.
Today, it is known that the 13 LAB symbionts produce
numerous extra-cellular proteins with a putative antimi-
crobial action during honey production [11, 49] that end up
in mature honey showing for the first time an equal and
standardized honey production by which honeybees pro-
duce their food [41]. Besides from the production of sev-
eral putative antimicrobial proteins, these symbionts was
shown to produce other substances including acetic and
formic acid, 2-heptanone, 3-hydroxy fatty acids, and
hydrogen peroxide that have antimicrobial and healing
properties [41] important for any future wound application.
Historical application of honey as a wound healing folk
medicine and recent research findings encouraged us to
perform a trial on hard-to-heal wounds in horses with a
standardized and previously used formulation. The
antimicrobial and pro-healing substances produced by the
LAB symbionts was reported often not being present in
mature honey including medical grade types due to the
non-viability of the LAB and the sensitive nature of the
bioactive substances in honeys high osmotic environment
[36]. The novel formulation therefore mimics fresh honey,
with a controlled standardized amount of the viable LAB in
a sterile honey matrix. It was recently tested in vitro for its
antimicrobial activity against human pathogens isolated
from 22 patients suffering from various chronic wound
types, and the results showed that the honeybee LAB for-
mulation was active against all isolates tested [37].
Since heavy bio-burden in wounds and chronic ulcers
promotes a prolonged inflammatory process and sometimes
counteracts healing [28, 53], we hypothesized that the
documented synergistic antimicrobial and healing proper-
ties of the honeybee LAB symbionts observed in our pre-
vious laboratory studies would be an ideal tool to test in
hard-to-heal wounds such as those seen in horses as a
wound model.
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Thus, there are three main aims of the present study.
First, to identify the microbiota of hard-to-heal equine
wounds in order to study the honeybee LAB formulation’s
mechanisms of antimicrobial action. Second, to investigate
if the honeybee LAB formulation could initiate wound
healing in hard-to-heal equine wounds and to detect
potential adverse effects. And finally, to investigate if this
formulation can be a stepping-stone when finding new




Ethical approval (M 18–13, 6th March 2013) was obtained,
regarding the use of the honeybee LAB formulation in
horses by the Ethical Committee on Animal Experiments in
Lund/Malmo¨, Sweden.
Treatment Formulation
The honeybee LAB formulation used in this study was
prepared as previously described [12] with some modifi-
cations. The mixture consisted of the 13 viable species of
LAB: Lactobacillus kunkeei Fhon2, Lactobacillus apino-
rum Fhon13, Lactobacillus mellifer Bin4, Lactobacillus
mellis Hon2, Lactobacillus kimbladii Hma2, Lactobacillus
melliventris Hma8, Lactobacillus helsingborgensis Bma5,
Lactobacillus kullabergensis Biut2, Lactobacillus apis
Hma11, Bifidobacterium coryneforme Bma6, Bifidobac-
terium sp. Bin7, Bifidobacterium asteroides Bin2 and Bi-
fidobacterium sp. Hma3 [9, 27, 40, 43] (total cell count of
all 13 LAB; 109 cfu/g honey), and their bioactive produced
substances in a matrix of Swedish sterilized heather (Cal-
luna vulgaris) honey. Sterilization of the honey was per-
formed at 102 C for 30 min resulting in disinfection
killing of most microbial life except certain bacterial
spores. To obtain a spray form, the same formulation was
mixed with sterile (autoclaved) water (1 g/2 ml) and
incubated at room temperature 1 day before treatment to
promote the growth of LAB and their production of
bioactive substances.
Experimental Design and Sample Collection
Ten horses with hard-to-heal wounds (wound duration
[1 year) diagnosed and pre-study treated by a veterinarian
were included in this pilot study. Each horse owner had to
fill in a protocol prior to the start of the study including
horses’ age, breed, previous treatments, and wound dura-
tion (Table 1). All wounds had signs of clinical infection at
study start. The horses’ age ranged between 6 and 23 years,
and all wounds were previously treated with different
topical agents without success (Table 1). Study period was
20 days or until healing if this occurred before 20 days.
The horse owners described and observed the treated
areas during the time of treatment. The wounds were first
visually judged, measured for size and photographed,
cleansed with saline solution, and then microbiological
samples were taken with a transport swab containing
charcoal (Sarstedt, Sweden) of the infected area for
microbial analyses both before and after treatment. The
honeybee LAB formulation was applied in original gel
form and as diluted with sterile water to a spray. It was
applied to the entire wound and covered with bandage. The
gel was applied directly to the moist wound. The spray was
used in the exudative parts of the wounds [25]. The wounds
were treated every 2 days and protocol data were recorded
at the same time. Data included clinical scores for
inflammation and healing, and signs of infection (smell,
pain, swelling, exudation, hyper-granulation and necrotic
tissue).
Bacterial Culture
Wound samples were received as swabs (described above)
1 day after sample were taken. A dilution series was made
using sterile PBS (pH 7.2), and samples were inoculated
onto tryptone soy broth agar (Oxoid, Basingstoke, Hamp-
shire, England) plates supplemented with, respectively,
horse blood and haematein for aerobic incubation and onto
equal plates and fastidious anaerobe agar (FAA, Oxoid)
plates, supplemented with horse blood, for the anaerobic
incubation at 37 C for up to 48 h. All colonies were
counted (total counts), and morphologically different
colonies were then picked for further identification.
Matrix-Assisted Laser Desorption Ionization–Time
of Flight (MALDI-TOF) Mass Spectrometry (MS)
MALDI-TOF MS was performed for the identification of
isolated microorganisms from horse wounds as previously
described [12, 44] with few modifications. Bacterial iso-
lates were cultured as described above and the direct
transfer formic acid method was used for all samples [44].
The experiments were performed in linear-positive mode
on Ultraflextreme MALDI-TOF/TOF MS instrument
(Bruker, Sweden) in a mass range of 2–20 kDa. Mass
spectra were analyzed using the FlexControl and MALDI
Biotyper 3.1 software with the BDAL-5627 reference
database (Bruker Daltronics, Sweden). Samples that were
not identified by MALDI-TOF MS were prepared for 16S
rRNA gene polymerase chain reaction (PCR) amplification
and sequencing.
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16S rRNA Genotypic Characterization
Characterization of unidentified organisms using 16S
rRNA gene sequencing was carried out according to pre-
vious work [39] with some modifications and described
briefly here. Colonies of each unidentified organism were
re-cultured for 24–48 h depending on their growth condi-
tions. DNA was extracted by bead extraction (Sigma-
Aldrich, USA) before PCR amplification of 16S rRNA
genes. One colony from the purified isolates was placed in
2.0 ml Eppendorf tubes together with 0.25 ml sterile water
and 10–15 glass beads (2.0 mm). Cells were disintegrated
by shaking for 45 min in an Eppendorf mixer 5432 (Ep-
pendorf, Hamburg, Germany). After centrifugation
(20,2009g for 5 min), 1 ll of the supernatant was used in
the following PCR reaction. Amplification of isolates was
Table 1 Participant information and treatment results about each
horses included in this study, containing horse breed, age, wound
duration, past treatments, underlying infection or disease, completed
treatment, percentage/number of completely healed wounds per horse,
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performed using universal primers ENV1 and ENV2
(TAG, Copenhagen, Denmark) designed to anneal to con-
served regions of bacterial 16S rRNA genes. The forward
primer ENV1 (50-AGA GTT TGA TII TGG CTC AG-30)
corresponded to positions 8–27 of Escherichia coli 16S
rRNA, and the reverse primer ENV2 (50-CGG ITA CCT
TGT TAC GAC TT-30) corresponded to positions
1511–1492. The PCR reaction contained 5 ll ten PCR
buffer (100 mmol/l Tris–HCl, 15 mmol/l MgCl2,
500 mmol/l KCl, pH 8.3), 200 lmol/l of each deoxyri-
bonucleotide triphosphate, 2.5 U of Taq DNA polymerase
(Roche Diagnostics, Mannheim, Germany), 10 pmol of
each primer, and 1–10 ll template in a total volume of
50 ll. Unpurified PCR products were sent for Value Read
sequencing at Eurofins MWG operon (Ebersberg, Ger-
many), and sequences were then searched against GenBank
(National Centre for Biotechnology Information (NCBI),
Rockville Pike, MD) using the advanced BLAST similarity
search option (available at http://www.ncbi.nlm.nih.gov).
Dual Culture Overlay Assay
Antimicrobial activity was measured by using dual culture
overlay assay as previously described [12, 35] with few
modifications. Honeybee LAB formulation in spray form
(10 ll, 108-10 cfu/disk) was added into a filter disk and
placed on de Man, Rogosa & Sharpe (MRS) (supplemented
with 0.1 % L-cysteine and 2 % fructose) agar plates fol-
lowed by overnight incubation at 35 C. Positive quality
controls strains (Culture collection isolates from American
Type Culture Collection (ATCC) of common wound
pathogens; S. aureus ATCC29213, E. coli ATCC 25922,
Staphylococcus epidermidis ATCC14990 and Proteus
vulgaris ATCC13315) and the identified wound pathogen
cultures were mixed with a 10 ml soft agar (0.8 %), con-
taining their respective growth medium, holding a tem-
perature of 42 C. Prior to mixing, pathogenic cultures
were adjusted to 108 cells per ml (OD of 0.5–0.6 at
540 nm). Each mixture of soft agar was poured as an over
layer on top of supplemented MRS plates with the over-
night cultivated LAB formulation. The plates were incu-
bated at 37 C for 24–48 h. Zone diameters were measured
from center of disk to zone edge and doubled for diameter.
Results
Wound Healing
Out of ten horses, seven completed the trial. One horse did
not complete due to unavailability of the treatment remedy,
while in two cases, the horse owners did not want to continue
as the wounds were too painful (horse six, eight, and nine).
This was unrelated to the formulation being tested. All
wounds treated with the honeybee LAB formulation had a
reduction in wound size and were healing effectively, or
were completely healed at the end of the study (Table 1). In
total, four out of seven horses had nearly complete healing,
with horse one, three, and seven having complete wound
closure at end of trial. In all cases, exudationwas reduced and
in all but two horses, pain was not obvious. In most cases, the
wounds began to heal after the first application, granulation
tissue was well established in some of the wounds, con-
traction of the wound was seen and finally epithelialization,
and complete wound healing was achieved. The mean
healing time was 16 days. Thematuration process seemed to
be very fast and even rapid hair regrowth was reported. In
some cases, thewoundswere not fully closed but healingwas
progressing (Horse five, seven, and ten). Epithelialization
appeared in the wounds of horse number one at 8 days and
the wounds were completely healed after 20 days (Fig. 1).
The wounds on horse number two began to heal after the first
treatment and were almost fully healed at 20 days. Horse
number three showed immediate signs of healing and the
wound closure was seen at day 16. In the case of horse
number four, all wounds became smaller and were almost
completely healed at the end of treatment. Horse number five
had wound closure in half of the four wounds that were
treated with some hair regrowth and the final two unhealed
wounds had commenced healing and become smaller. The
wounds of horse number seven healed in 10 days. In horse
number ten, thewounds started to heal after one treatment yet
had not fully healed when the study was completed (Fig. 1).
No adverse effects were reported in any of the horses
including in the pilot study.
Microbial Identification
All selected isolates were identified using MALDI-TOF flex
analysis or with 16S rRNA gene sequencing (Table 2).
Twenty-seven bacterial genera and one yeast species (Can-
dida) were identified from the wound samples with 53 iden-
tified to species level (some only to genus), the most
commonly isolated belonging to Staphylococcus (12 species),
colonizing 90 % of all wounds. Other commonly found spe-
cies belonged to the following genera Corynebacterium ([5
species), Streptococcus (5 species), and Acinetobacter genera
([4 species) (Table 2). Themajority of genera identifiedwere
gram-positive bacteria, and 56 % of all bacteria identified.
Discussion
Like human chronic wounds, equine wounds can be
extremely difficult to heal due to many different factors
[59]. Some have suggested that the healing capability of
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equine wounds are very similar to human wounds and that
they are an important wound model to investigate in
regards to wound management [51]. Many treatment
options have been investigated in the past few years for
treating hard-to-heal wounds; however, none of them seem
to be optimal for an effective management [32, 58]. Honey
as a wound dressing provides a moist environment but also
antibacterial and anti-oxidative action from the presence of
high osmosis, hydrogen peroxide, and other substances
[15, 26, 30]. It has also been reported to reduce swelling
and inflammation and can decrease the healing time by
stimulating angiogenesis, granulation, and epithelialization
[2, 15]. Studies have claimed Manuka honey to be effective
in equine wound healing [21] including a study showing
Manuka honeys effect on reduction in wound size yet at
35 days none of the wounds were fully closed [7]. In the
case of our study, we saw some of the wounds close in a
short space of time (Table 1), suggesting the LAB and
honey together have added benefits for wound healing than
just honey on its own. Heather honey was also shown to be
effective against bacteria associated with equine wounds in
comparison to other honey types [13]. This is possibly due
to the slightly higher water content in heather honey than in
other honey types, which allows for greater activity of the
LAB substances and their viability. Another study has also
shown the effectiveness of a hydrogen peroxide (H2O2)
topical ointment in the treatment of equine wounds [52]
which could explains honeys action. H2O2 is produced in
large quantities by the LAB symbionts [33] and by the
honeybee itself that is inactivated during honey ripening,
but then reactivated when diluted by the wound exudate
leading to its slow release [3]. This is why we believe that
honey is the optimal treatment medium for its beneficial
properties in wound healing and for the survival of the
LAB symbionts that need food (honey) to multiply and
produce bioactive substances [45, 56]. Previous research
has demonstrated that many of the specific therapeutic
properties of honey are attributed to the 13 LAB symbionts
used in this study, for instance L. apinorum Fhon13 pro-
duces 2-heptanone which has anesthetic qualities [42], five
LAB strains (L. apis Hmall, L. kimbladii Hma2, L. mel-
liventris Hma8, L. helsingborgensis Bma5, and L. kul-
labergensis Biut2) produce H2O2, and the production of
hydroxy fatty acids by L. apinorum Fhon13, L. kunkeei
Fhon2, Bifidobacterium asteroides Bin2, and Bifidobac-
terium species Bin7. [41]. Remarkably, these 13 LAB
symbionts are viable and active in large quantities in fresh
honey (approximately 108 per gram fresh honey, depending
on the honey type) [39, 54, 56] and are one of the main
contributors’ to antimicrobial activity associated with
honey due to their production of several bioactive sub-
stances that build up this defense against pathogens making
it impossible for them to survive [41]. This can be observed
from the in vitro experiments both in this study and in
previous studies [30, 37], in which the antagonistic action
against environmental and wound pathogens of honeybee
LAB [33] in combination with honey [34] is very effective
(Fig. 2). On the other hand, the matrix composed of only
the heather honey with no viable LAB had no antimicrobial
action [12].
In the case of equine wounds, a short healing time is
extremely important as horses will be exposed to the out-
side hostile environment like moist mud and grass, in
which exposure to microbes is certain. The diagnosed
Pastern Dermatitis wound that horse number one had was
healed completely in 20 days. Pastern Dermatitis is diag-
nosed as a syndrome more so than disease due to the wide
variety of genetic and environmental factors that exacer-
bate the condition making it difficult to manage [18]. The
small wounds of horse number two, healed significantly
slower compared to the other horses (Post study follow up
with owner revealed wounds had healed at day 30).
However, the reasoning for this could be that this horse was
much older (23-year old) and had an underlying condition
Fig. 1 Pictures before treatment (top) and after (bottom) treatment of the wounds for the seven horses that completed the study with the
honeybee LAB formulation. The horse owners took photos as outlined in protocol
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Table 2 Identified genus and species from all isolated bacteria and yeasts from the wound with corresponding results for in vitro antimicrobial
testing
Genus Number of infected
horses (n = 10)
Species Number of infected
horses (n = 10)
In vitro inhibition
with formulation























































































Macrococcus 3 SUb 3 Y
























Klebsiella 2 K. oxytoca complex 1 Y












Micrococcus 2 SUb 2 Y
Proteus 2 P. vulgaris 2 Y
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of chronic lymphangitis, which caused substantial inflam-
mation and edema in the limbs. Horse number ten showed
a slow healing time that could be explained by the long
duration of this wound (4.5 years). Even though many of
the wounds were slow to heal, we saw that in some cases
the wounds healed in a short amount of time compared to
studies that used honey alone where only reduction in
wound size is seen [6, 7].
In the case of horse number seven we noticed the
wounds healed in 10 days, which according to the owner
was the first time they were healed since in 20 months.
Interestingly this wound showed the presence of Candida,
a yeast, as well as Staphylococcus species (Table 2), sug-
gesting the honeybee LAB formulation may have variation
in its antimicrobial action against both yeasts and bacteria.
Previous results have shown that the LAB species produce
different inhibitory patterns when in contact with different
bacteria and yeasts and the level of activity is species
dependent, with some more effective than others
[23, 41, 56]. The different LAB species produce a great
variety of substances in which some could be more effec-
tive against yeasts than bacteria, for example, L. apinorum
Fhon13 produces 3-hydroxy fatty acids that have been
shown to have antifungal activity [47]. Additionally the
LAB strains produce large amounts of organic acids which
have multiple functions including acetic acid which is
known to be effective against P. aeruginosa, a significant
wound pathogen [38]. All these bioactive substances in
combination together make a formulation with the viable
and co-working LAB species that can produce these sub-
stances in the wound environment when needed, making
them a very attractive tool against a wide range of patho-
gens [30, 36, 37]. This broad spectrum antimicrobial
activity of the LAB is perfect for the use in wound man-
agement. As like human wounds, we observed the equine
wounds are colonized by multiple species and genera at the
same time, and these LAB symbionts can work synergis-
tically in the wound environment. Similar to human
chronic wounds, we observed that all wounds were colo-
nized by more than one bacterial species (Table 2).
We observed 90 % of horses were colonized by Staphy-
lococcus species (Table 2). Staphylococcus species are a
very significant wound pathogen in both humans and ani-
mals, and it is believed by many that S. aureus and other
species are heavily involved in the hard-to-heal nature of
equine wound infection [13, 57]. Due to the global increase
of antibiotic-resistant strains such asMRSAandb-lactamase
producing pathogens, development of alternative treatments
for both human and equine wounds is urgent [10, 14]. Fur-
thermore, animals infected with MRSA and other antibiotic-
resistant pathogens have also increased in the last decade
[5, 57] and are nowoften reported by veterinary practices and
farm owners [4, 57]. Previous research points toward the
utilization of these newly characterized LAB symbionts as a
Table 2 continued
Genus Number of infected
horses (n = 10)
Species Number of infected
horses (n = 10)
In vitro inhibition
with formulation






Bacteroides 1 B. pyogenes 1 NDc
Peptonophilus 1 P. indolicus 1 Y
Pasteurella 1 P. canis 1 Ya
Alcaligenes 1 A. faecalis 1 NDc
Streptomyces 1 S. badius NDc











Brevibacterium 1 SUb 1 NDc
Gordonia 1 G. hirsuta 1 NDc
Pantoea 1 P. agglomerans 1 Y
Carnobacter 1 SUb 1 NDc
Citrobacter 1 C. braakii 1 Y
a Y corresponds to inhibition with hazy growth throughout zone
b SU—Species unidentified
c ND—Not determined
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new antibiotic alternative due to their antimicrobial effect
against some antibiotic-resistant pathogens found in
humans, including MRSA [41, 56].
It is clear from the wide microbial variety identified
from the equine wounds that many could be causing the
chronic symptoms associated with non-healing [58, 59].
Several possibly colonizing the wound from their natural
habitat (soil, grass) e.g., Acinetobacter species [24]. A
review of research by Westgate and colleagues summarize
that generally gram-positive bacteria make up the common
equine skin flora which is significant to the horses health
but in chronic wound colonization, these bacteria can act as
opportunistic pathogens e.g., S. aureus and Streptococcus
species [58]. It does seem when looking at this study,
however, that Staphylococcus species are at the forefront of
chronic wound infection in horses.
This was a small pilot study aimed at investigating
potential microbial reduction in wound bacteria and stim-
ulation of wound healing in an animal model. It was also
aimed at detecting potential adverse effects in which we
can now confirm that the formulation is not harmful in the
case of topical application on horses. It is important to not
also that these were ‘‘real’’ wounds and not manufactured
as seen in some studies [7], therefore represent a more
realistic infection for the horses. A placebo-controlled
study comparing this formulation is the next step to con-
firm these results and investigate the possibilities to apply
the formulation in humans. In this study, each wound was
its own historical control. Previous unsuccessful treatments
(Table 1) of these wound also serves as a reference and
strongly demonstrate the significance of the new type of
treatment used in this work.
Conclusion
The rapid, painless healing of hard-to-heal equine wounds
gives us reason to believe that the honeybee LAB formula-
tion presents a new topical option in future wound healing.
This new treatment may be a stepping-stone toward an
alternative solution for treating other infected wounds in
animals and humans and warrants further investigation.
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Fig. 2 Examples of inhibition zones of the wound bacterial isolates
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equorum (e), and Enterococcus faecium (f)
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